Transapical access: a complementary access for tevar in a stanford type a dissection

Introduction/Objectives: Type A aortic dissection (AD) usually requires urgent surgical treatment and aortic segment replacement remains the gold standard. However, it is a very aggressive procedure and some patients are considered too frail for this treatment. Nowadays, endovascular repair represents an alternative treatment but still without precise indications. Our objective is to present a case of hybrid treatment of a type A AD with resource a transapical cardiac access. Material/Methods: Clinical case and literature review. Results: A 65-year-old man with history of chronic pulmonary obstructive disease, atrial fibrillation and hypertension came to the emergency department with abdominal pain. He underwent angio-CT that revealed type A AD with an PAU in the ascending aorta (AA). After evaluation by cardiac surgery, he was considered too frail for conventional surgery. Angio-CT was repeated after two weeks of medical treatment and revealed false aneurysm growth, with imminent risk of rupture. We thought about endovascular treatment and different options were considered, the final decision was to propose the patient for an hybrid treatment. The procedure was started with a femoro-rigth axilar bypass and emboli­zation of the brachyocephalic trunk. Then an endoprosthesis (Valiant®) was delivered below the left subclavian artery and two periscopes (Viabahn®) were progressed form left carotid and axillar arteries and the second endoprosthesis (Valiant®) was released into the aorta, inside the first, with coverage of the left common carotid and subclavian, and the Viabahn® were released. After multiple attempts, it was not possible to progress the third endoprosthesis AA because of lack of support and hemodynamic instability whenever the guidewire was progressed for the left ventricle and the procedure was interrupted. Subsequently performed angio-CT revealed permeable AA dissection and untreated false aneurysm. We discussed other options and an anterograde (transapical) approach was considered to progress a guidewi­re on through-and-through to achieve the support we need to progress the endoprothesis. With the support of the cardiac surgery the cardiac apex was punctured and using the through-and-through technique the guide wire was progressed to femoral artery which allowed advancement of the endoprosthesis (Valiant®) through the retrograde pathway and release under rapid-pacing in the AA with good final result. Discussion/Conclusions: Endovascular treatment is an alternative in patients of high clinical risk and adequate anato­mical characteristics, yet technically challenging. When the retrograde progression of the endoprosthesis is not achieved, the transapical cardiac approach is an alternative to be considered.

Saved in:
Bibliographic Details
Main Authors: Antunes,Inês, Machado,Rui, Loureiro,Luís, Pereira,Carlos, Rego,Duarte, Ferreira,Vitor, Gonçalves,João, Teixeira,Gabriela, Veiga,Carlos, Mendes,Daniel, Almeida,Rui de
Format: Digital revista
Language:English
Published: Sociedade Portuguesa de Angiologia e Cirurgia Vascular 2017
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-706X2017000300008
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1646-706X2017000300008
record_format ojs
spelling oai:scielo:S1646-706X20170003000082018-08-13Transapical access: a complementary access for tevar in a stanford type a dissectionAntunes,InêsMachado,RuiLoureiro,LuísPereira,CarlosRego,DuarteFerreira,VitorGonçalves,JoãoTeixeira,GabrielaVeiga,CarlosMendes,DanielAlmeida,Rui de Transapical access endovascular treatment type A aortic dissection Introduction/Objectives: Type A aortic dissection (AD) usually requires urgent surgical treatment and aortic segment replacement remains the gold standard. However, it is a very aggressive procedure and some patients are considered too frail for this treatment. Nowadays, endovascular repair represents an alternative treatment but still without precise indications. Our objective is to present a case of hybrid treatment of a type A AD with resource a transapical cardiac access. Material/Methods: Clinical case and literature review. Results: A 65-year-old man with history of chronic pulmonary obstructive disease, atrial fibrillation and hypertension came to the emergency department with abdominal pain. He underwent angio-CT that revealed type A AD with an PAU in the ascending aorta (AA). After evaluation by cardiac surgery, he was considered too frail for conventional surgery. Angio-CT was repeated after two weeks of medical treatment and revealed false aneurysm growth, with imminent risk of rupture. We thought about endovascular treatment and different options were considered, the final decision was to propose the patient for an hybrid treatment. The procedure was started with a femoro-rigth axilar bypass and emboli­zation of the brachyocephalic trunk. Then an endoprosthesis (Valiant®) was delivered below the left subclavian artery and two periscopes (Viabahn®) were progressed form left carotid and axillar arteries and the second endoprosthesis (Valiant®) was released into the aorta, inside the first, with coverage of the left common carotid and subclavian, and the Viabahn® were released. After multiple attempts, it was not possible to progress the third endoprosthesis AA because of lack of support and hemodynamic instability whenever the guidewire was progressed for the left ventricle and the procedure was interrupted. Subsequently performed angio-CT revealed permeable AA dissection and untreated false aneurysm. We discussed other options and an anterograde (transapical) approach was considered to progress a guidewi­re on through-and-through to achieve the support we need to progress the endoprothesis. With the support of the cardiac surgery the cardiac apex was punctured and using the through-and-through technique the guide wire was progressed to femoral artery which allowed advancement of the endoprosthesis (Valiant®) through the retrograde pathway and release under rapid-pacing in the AA with good final result. Discussion/Conclusions: Endovascular treatment is an alternative in patients of high clinical risk and adequate anato­mical characteristics, yet technically challenging. When the retrograde progression of the endoprosthesis is not achieved, the transapical cardiac approach is an alternative to be considered.info:eu-repo/semantics/openAccessSociedade Portuguesa de Angiologia e Cirurgia VascularAngiologia e Cirurgia Vascular v.13 n.3 20172017-12-01info:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-706X2017000300008en
institution SCIELO
collection OJS
country Portugal
countrycode PT
component Revista
access En linea
databasecode rev-scielo-pt
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Antunes,Inês
Machado,Rui
Loureiro,Luís
Pereira,Carlos
Rego,Duarte
Ferreira,Vitor
Gonçalves,João
Teixeira,Gabriela
Veiga,Carlos
Mendes,Daniel
Almeida,Rui de
spellingShingle Antunes,Inês
Machado,Rui
Loureiro,Luís
Pereira,Carlos
Rego,Duarte
Ferreira,Vitor
Gonçalves,João
Teixeira,Gabriela
Veiga,Carlos
Mendes,Daniel
Almeida,Rui de
Transapical access: a complementary access for tevar in a stanford type a dissection
author_facet Antunes,Inês
Machado,Rui
Loureiro,Luís
Pereira,Carlos
Rego,Duarte
Ferreira,Vitor
Gonçalves,João
Teixeira,Gabriela
Veiga,Carlos
Mendes,Daniel
Almeida,Rui de
author_sort Antunes,Inês
title Transapical access: a complementary access for tevar in a stanford type a dissection
title_short Transapical access: a complementary access for tevar in a stanford type a dissection
title_full Transapical access: a complementary access for tevar in a stanford type a dissection
title_fullStr Transapical access: a complementary access for tevar in a stanford type a dissection
title_full_unstemmed Transapical access: a complementary access for tevar in a stanford type a dissection
title_sort transapical access: a complementary access for tevar in a stanford type a dissection
description Introduction/Objectives: Type A aortic dissection (AD) usually requires urgent surgical treatment and aortic segment replacement remains the gold standard. However, it is a very aggressive procedure and some patients are considered too frail for this treatment. Nowadays, endovascular repair represents an alternative treatment but still without precise indications. Our objective is to present a case of hybrid treatment of a type A AD with resource a transapical cardiac access. Material/Methods: Clinical case and literature review. Results: A 65-year-old man with history of chronic pulmonary obstructive disease, atrial fibrillation and hypertension came to the emergency department with abdominal pain. He underwent angio-CT that revealed type A AD with an PAU in the ascending aorta (AA). After evaluation by cardiac surgery, he was considered too frail for conventional surgery. Angio-CT was repeated after two weeks of medical treatment and revealed false aneurysm growth, with imminent risk of rupture. We thought about endovascular treatment and different options were considered, the final decision was to propose the patient for an hybrid treatment. The procedure was started with a femoro-rigth axilar bypass and emboli­zation of the brachyocephalic trunk. Then an endoprosthesis (Valiant®) was delivered below the left subclavian artery and two periscopes (Viabahn®) were progressed form left carotid and axillar arteries and the second endoprosthesis (Valiant®) was released into the aorta, inside the first, with coverage of the left common carotid and subclavian, and the Viabahn® were released. After multiple attempts, it was not possible to progress the third endoprosthesis AA because of lack of support and hemodynamic instability whenever the guidewire was progressed for the left ventricle and the procedure was interrupted. Subsequently performed angio-CT revealed permeable AA dissection and untreated false aneurysm. We discussed other options and an anterograde (transapical) approach was considered to progress a guidewi­re on through-and-through to achieve the support we need to progress the endoprothesis. With the support of the cardiac surgery the cardiac apex was punctured and using the through-and-through technique the guide wire was progressed to femoral artery which allowed advancement of the endoprosthesis (Valiant®) through the retrograde pathway and release under rapid-pacing in the AA with good final result. Discussion/Conclusions: Endovascular treatment is an alternative in patients of high clinical risk and adequate anato­mical characteristics, yet technically challenging. When the retrograde progression of the endoprosthesis is not achieved, the transapical cardiac approach is an alternative to be considered.
publisher Sociedade Portuguesa de Angiologia e Cirurgia Vascular
publishDate 2017
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-706X2017000300008
work_keys_str_mv AT antunesines transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT machadorui transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT loureiroluis transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT pereiracarlos transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT regoduarte transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT ferreiravitor transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT goncalvesjoao transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT teixeiragabriela transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT veigacarlos transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT mendesdaniel transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
AT almeidaruide transapicalaccessacomplementaryaccessfortevarinastanfordtypeadissection
_version_ 1756003331384279040